Company: ALGN
Filing Date: 2025-07-02
Form Type: 8-K
Source: 0001097149-25-000050
Chunk: 0

Company: ALIGN TECHNOLOGY INC
Filing Date: 2025-07-02
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

The Board of Directors (the “ Board”) of Align Technology, Inc. (the “ Company”) appointed Britt Vitalone, 56, to the Board, effective July 2, 2025. In connection with this appointment, the Board increased the size of the Board from ten to eleven directors. The Company expects Mr. Vitalone to stand for election at the next annual meeting of stockholders, which is expected to be held in May 2026. The Board also appointedMr. Vitalone to serve on the AuditCommittee, effective July 2, 2025.

Mr. Vitalone will participate in the compensation program for non-employee directors as described under the heading“ Director Compensation” in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission (the “ SEC”) on April 8, 2025, except that the annual retainer and equity grant will be prorated to reflect service from the date of appointment until the Company’s annual meeting of stockholders in 2026.

Mr. Vitalone has also entered into a director indemnification agreement with the Company, the form of which is disclosed as Exhibit 10.21 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025, and which is incorporated by reference herein.

There is no arrangement or understanding between Mr. Vitalone and any other person pursuant to which he was selected as a director. Mr. Vitalone has no direct or indirect material interest in any existing or currently proposed transaction that would require disclosure under Item 404(a) of Regulation S-K.

A copy of the press release announcing Mr. Vitalone’s appointment to the Board is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.